David Aufrere Oxlade
Vorsitzender bei Oxford Gene Technology Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| John George Anson | M | 64 |
Oxford Gene Technology IP Ltd.
 Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK.
Oxford Gene Technology (Operations) Ltd.
 Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999.
Oxford Gene Technology Ltd.
 Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | 18 Jahre |
| Michael Robert Evans | M | 66 |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999.
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK.
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | 19 Jahre |
| Kenji Tsujimoto | M | 53 |
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK.
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999.
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | - |
| David Owen | M | - |
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | 19 Jahre |
| David Andrew Arlwydd Owen | M | - |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999.
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK. | - |
| Simon James Yvon Saxby | M | 65 |
Cobra Biologics Holdings Ltd.
 Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | 16 Jahre |
| Tony Lenhardt | M | - |
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | 19 Jahre |
| Gregory Allen Williamson | M | 56 |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David A. Thatcher | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| David Philip Bloxham | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| Michael Gatenby | M | 79 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| Danny R. Chapchal | M | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
| Nigel Slater | M | 70 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 13 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- David Aufrere Oxlade
- Persönliches Netzwerk
